Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Avandia Recall Decision In Europe To Be Announced On Or About September 23, 2010
Will This September 2010 EMA Committee Meeting Result In A Consensus, Unlike July 2010 FDA Avandia Panel Voting (Posted by Tom Lamb at DrugInjuryWatch.com) _______________________________________________________________________ UPDATE: FDA Keeps Diabetes Pill on Market; Europe Suspends Sales …
-
Will The FDA Follow The EMA And Order A Meridia Recall After Its September 2010 Advisory Committee Meeting
NEJM Editorial: There Should Be A Meridia Recall As The Risk Of Heart-Related Side Effects Is Greater Than Any Weight-Loss Benefit (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid FDA Safety…
-
10,000 Avandia Lawsuits Settled For $460 Million While FDA Considers Possible Avandia Recall
During July 13-14, 2010 FDA Advisory Committee Meeting, Glaxo Settles Most Of The 13,000 Avandia Court Cases (Posted by Tom Lamb at DrugInjuryWatch.com) Bloomberg reporters Jef Feeley and Trista Kelley broke the news of…
-
Blood Pressure Medication Benicar (Olmesartan) Might Be Unsafe For Some Patients
Two Clinical Studies Find Patients With Type 2 Diabetes Taking Benicar Had Higher Rate Of Death From A Cardiovascular Cause (Posted by Tom Lamb at DrugInjuryWatch.com) On June 11, 2010 the FDA announced that…
-
Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S.
Bayer Says YAZ / Yasmin Safety Profile Is Comparable To Older Birth Control Pills, But European Regulators See Possible Increased Risk Of Blood Clot Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer…
-
Study About Using Glaxo’s Avodart To Prevent Prostate Cancer Finds Possible Heart Risk
Higher Rate Of Cardiac Failure In Men Taking Avodart (Dutasteride) – 0.7 Percent vs. 0.4 Percent For Those Taking The Placebo (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 1, 2010 edition of…
-
Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group
Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion (Posted by Tom Lamb at DrugInjuryWatch.com)Let us start with this relatively recent medical journal article, "Postmarketing study of…
-
YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer
Company Annual Report 2009: "Bayer believes that it has meritorious defenses and intends to defend itself vigorously." (Posted by Tom Lamb at DrugInjuryWatch.com) The Bayer Annual Report for 2009, at page 243, provides some updated…
-
How Electronic Medical Records Review Might Help FDA Identify Unsafe Drugs Sooner
Study Says Using Such Data Would Have Resulted In Faster Safety Signal Detection For Increased Risk Of Heart Attacks With Avandia Use (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical journal article suggests…
-
Factors In Assessing Association Between Valvular Heart Disease And Use Of Dostinex Or Permax
Two Medical Journal Articles Review The Published Research And Suggest Ways To Avoid Cardiac Valve Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2007 the FDA announced that Permax (pergolide) would be voluntarily…